Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 18, Pages 10161
Publisher
MDPI AG
Online
2021-09-21
DOI
10.3390/ijms221810161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases
- (2021) Rachayeeta Deb et al. NEUROTOXICITY RESEARCH
- Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
- (2021) Xiangpeng Ren et al. Frontiers in Neuroscience
- The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
- (2021) Johanna Michael et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
- (2021) Tapan Behl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-Administration of Gagam-Sipjeondaebo-Tang and Ibuprofen Alleviates the Inflammatory Response in MPTP-Induced Parkinson’s Disease Mouse Model and RAW264.7 Macrophages
- (2021) Sodam Won et al. Pathogens
- Expatiating the impact of anthropogenic aspects and climatic factors on long-term soil monitoring and management
- (2021) Simona Bungau et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy
- (2021) Lalita Subedi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PGC-1s in the Spotlight with Parkinson’s Disease
- (2021) Elena Piccinin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glutathione in the Brain
- (2021) Koji Aoyama INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Parkinson's Disease Genetics and Pathophysiology
- (2021) Gabriel E. Vázquez-Vélez et al. Annual Review of Neuroscience
- Effect of dietary vitamins C and E on the risk of Parkinson's disease: A meta-analysis
- (2021) Min Cheol Chang et al. CLINICAL NUTRITION
- Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
- (2021) Johan Wallin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Mechanistic approach of Peroxisome Proliferator-Activated Receptors and its subtypes on Clinical and preclinical model of Neurodegenerative disorders
- (2021) Jinu Avarachan et al. Research Journal of Pharmacy and Technology
- Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
- (2020) Bin Peng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative Disorders
- (2020) Sylwia Wójtowicz et al. NEUROCHEMICAL RESEARCH
- PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
- (2020) Sergio Rius-Pérez et al. Oxidative Medicine and Cellular Longevity
- Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
- (2020) Mónica Gómez-Benito et al. Frontiers in Pharmacology
- Role of Peroxisome Proliferated Activated Receptor gamma (PPARγ) in Different Disease States: Recent Updates
- (2020) Suvadeep Mal et al. CURRENT MEDICINAL CHEMISTRY
- Nutraceuticals in Neurological Disorders
- (2020) Rashita Makkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice
- (2020) TCS Costa et al. Journal of Neuroimmune Pharmacology
- PPARδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease
- (2020) Meric A. Altinoz et al. MOLECULAR ASPECTS OF MEDICINE
- The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
- (2020) Chien Tai Hong et al. Nutrients
- Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms
- (2020) Csaba Váradi Biology-Basel
- Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration
- (2020) B. Mahalakshmi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
- (2020) Sandro Percário et al. Oxidative Medicine and Cellular Longevity
- Neuroinflammatory responses in Parkinson’s disease: relevance of Ibuprofen in therapeutics
- (2020) Ashish Singh et al. INFLAMMOPHARMACOLOGY
- Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy
- (2020) Anna K. Strosznajder et al. NEUROMOLECULAR MEDICINE
- Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease
- (2020) Sarah Dassati et al. NEUROPHARMACOLOGY
- Circuit Mechanisms of Parkinson’s Disease
- (2019) Matthew M. McGregor et al. NEURON
- Parkinson's Disease and Parkinsonism
- (2019) Michael T Hayes AMERICAN JOURNAL OF MEDICINE
- Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study
- (2019) Dilini Rathnayake et al. BMC Neurology
- Parkinson’s Disease in Women and Men: What’s the Difference?
- (2019) Silvia Cerri et al. Journal of Parkinsons Disease
- GBA1-associated parkinsonism
- (2019) Emory Ryan et al. CURRENT OPINION IN NEUROLOGY
- DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
- (2019) Mariaelena Repici et al. Journal of Clinical Medicine
- The genetics of Parkinson disease
- (2018) Hao Deng et al. AGEING RESEARCH REVIEWS
- The Role of LRRK2 in Neurodegeneration of Parkinson Disease
- (2018) Qin Rui et al. Current Neuropharmacology
- Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion
- (2018) Elisabeth G. Hain et al. Journal of Neuroinflammation
- Impact of ethnicity on the natural history of Parkinson disease
- (2018) Anna Sauerbier et al. MEDICAL JOURNAL OF AUSTRALIA
- Caffeine and Parkinson disease
- (2018) David G. Munoz et al. NEUROLOGY
- Effect of montelukast in experimental model of Parkinson’s disease
- (2018) Vetrivel Babu Nagarajan et al. NEUROSCIENCE LETTERS
- Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2018) Zexu Wei et al. Frontiers in Molecular Neuroscience
- Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson’s disease model
- (2018) Yujeong Lee et al. BRAIN RESEARCH
- Alcohol consumption and risk for Parkinson’s disease: a systematic review and meta-analysis
- (2018) Félix Javier Jiménez-Jiménez et al. JOURNAL OF NEUROLOGY
- Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects
- (2018) Riham M. Mansour et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
- (2018) Zaza Khuchua et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease
- (2018) Meira Maria Forcelini Machado et al. Pharmacological Reports
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- The relevance of gender in Parkinson’s disease: a review
- (2017) Marina Picillo et al. JOURNAL OF NEUROLOGY
- Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease
- (2017) Patrick K.K. Yeung et al. NEUROBIOLOGY OF AGING
- Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson’s disease
- (2017) Hannah Jang et al. NEUROREPORT
- Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease
- (2017) Yanqin Wang et al. PPAR Research
- Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
- (2017) Qian Gou et al. Oncotarget
- Glucocerebrosidase Mutations in Parkinson Disease
- (2017) Grace O’Regan et al. Journal of Parkinsons Disease
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Fatty acids, eicosanoids and PPAR gamma
- (2016) Rachel Marion-Letellier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
- (2016) Juan Carlos Corona et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2016) Lauren Hirsch et al. NEUROEPIDEMIOLOGY
- α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
- (2016) Roberto Di Maio et al. Science Translational Medicine
- Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements
- (2016) Jian-Yong Wang et al. Scientific Reports
- The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication
- (2016) Irum Javaid Siddiqui et al. Scientific Reports
- Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
- (2016) Lingjia Xu et al. Parkinsons Disease
- The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain
- (2016) Eduardo Maria Normando et al. Acta Neuropathologica Communications
- Association between Parkinson’s Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis
- (2016) Charles B. Breckenridge et al. PLoS One
- Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
- (2016) Alvaro Sanchez-Martinez et al. Scientific Reports
- Management of Parkinson׳s disease: Current and future pharmacotherapy
- (2015) Ashish Kumar Kakkar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Understanding Parkinson Disease
- (2015) Apoorva Gopalakrishna et al. JOURNAL OF NEUROSCIENCE NURSING
- Increased Risk of Parkinson Disease in Patients With Carbon Monoxide Intoxication
- (2015) Ching-Yuan Lai et al. MEDICINE
- Head injury and risk for Parkinson disease: Results from a Danish case-control study
- (2015) L. Kenborg et al. NEUROLOGY
- The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
- (2015) Alicia M. Pickrell et al. NEURON
- Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle
- (2015) S. Pablo Sardi et al. PROGRESS IN NEUROBIOLOGY
- Mitochondrial Dysfunction in Parkinson's Disease
- (2015) Hyo Eun Moon et al. Experimental Neurobiology
- The Ubiquitin-Proteasome System in Neurodegeneration
- (2014) Chris McKinnon et al. ANTIOXIDANTS & REDOX SIGNALING
- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
- (2014) Karen E. Murphy et al. BRAIN
- A PPAR-β/δ Agonist is Neuroprotective and Decreases Cognitive Impairment in a Rodent Model of Parkinson’s Disease
- (2014) Nihar Das et al. CURRENT NEUROVASCULAR RESEARCH
- mitoNEET as a novel drug target for mitochondrial dysfunction
- (2014) Werner J. Geldenhuys et al. DRUG DISCOVERY TODAY
- Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction
- (2014) Eric S. Luth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alcohol intake and risk of Parkinson's disease: A meta-analysis of observational studies
- (2014) Dongfeng Zhang et al. MOVEMENT DISORDERS
- PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
- (2014) Juan Carlos Corona et al. NEUROCHEMICAL RESEARCH
- Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease
- (2014) B. Ritz et al. NEUROLOGY
- PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease
- (2014) Janaína K. Barbiero et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Mutations in theATP13A2Gene and Parkinsonism: A Preliminary Review
- (2014) Xinglong Yang et al. Biomed Research International
- Exercise: Is it a neuroprotective and if so, how does it work?
- (2013) Michael J. Zigmond et al. PARKINSONISM & RELATED DISORDERS
- Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models
- (2012) Nian Xiong et al. CRITICAL REVIEWS IN TOXICOLOGY
- In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease
- (2012) Dirk A. Ridder et al. EXPERIMENTAL NEUROLOGY
- Lipolytic Products Activate Peroxisome Proliferator-activated Receptor (PPAR) α and δ in Brown Adipocytes to Match Fatty Acid Oxidation with Supply
- (2012) Emilio P. Mottillo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6
- (2012) Prachi Bajpai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
- (2012) Yu-Chang Chen et al. MOLECULAR NEUROBIOLOGY
- The Bioenergetic Status Relates to Dopamine Neuron Loss in Familial PD with PINK1 Mutations
- (2012) Rüediger Hilker et al. PLoS One
- Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence
- (2012) Edward A. Lock et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
- (2011) Giuseppa Mudò et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Rotenone, Paraquat, and Parkinson’s Disease
- (2011) Caroline M. Tanner et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
- (2011) Christine R Swanson et al. Journal of Neuroinflammation
- Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells
- (2011) P. Seibler et al. JOURNAL OF NEUROSCIENCE
- Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease
- (2011) Kunikazu Tanji et al. NEUROBIOLOGY OF DISEASE
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
- (2010) Lydia Alvarez-Erviti et al. ARCHIVES OF NEUROLOGY
- Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening
- (2010) Werner J. Geldenhuys et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Ubiquitin Enzymes, Ubiquitin and Proteasome Activity in Blood Mononuclear Cells of MCI, Alzheimer and Parkinson Patients
- (2010) C. Ullrich et al. Current Alzheimer Research
- Regulation of mitochondrial biogenesis
- (2010) François R. Jornayvaz et al. Essays in Biochemistry
- Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update
- (2010) Karen Nuytemans et al. HUMAN MUTATION
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1α enhances α-synuclein oligomerization and down regulates AKT/GSK3β signaling pathway in human neuronal cells that inducibly express α-synuclein
- (2010) Abdul Shukkur Ebrahim et al. NEUROSCIENCE LETTERS
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Professional exposure to pesticides and Parkinson disease
- (2009) Alexis Elbaz et al. ANNALS OF NEUROLOGY
- Parkinson's disease: from monogenic forms to genetic susceptibility factors
- (2009) S. Lesage et al. HUMAN MOLECULAR GENETICS
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- Incidence and remaining lifetime risk of Parkinson disease in advanced age
- (2009) J. A. Driver et al. NEUROLOGY
- Molecular mechanism of PPAR in the regulation of age-related inflammation
- (2008) Jae Heun Chung et al. AGEING RESEARCH REVIEWS
- Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
- (2008) Dong-Pyo Hong et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Targeting PPAR as a therapy to treat multiple sclerosis
- (2008) John J Bright et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPAR: a therapeutic target in Parkinsons disease
- (2008) Rajnish K. Chaturvedi et al. JOURNAL OF NEUROCHEMISTRY
- Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
- (2008) Bin Xing et al. Journal of Neuroinflammation
- Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
- (2008) Payal N. Gandhi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Parkinson disease: primacy of age as a risk factor for mitochondrial dysfunction
- (2008) Theodore B. VanItallie METABOLISM-CLINICAL AND EXPERIMENTAL
- Peroxisome Proliferator-Activated Receptor-γin Amyotrophic Lateral Sclerosis and Huntington’s Disease
- (2008) Mahmoud Kiaei PPAR Research
- Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague–Dawley rats
- (2007) Randy L. Hunter et al. NEUROSCIENCE LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started